Skip to main content

Advertisement

Log in

Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO

  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

The chemokine receptor CXCR4 regulates neuronal survival and differentiation and is involved in a number of pathologies, including cancer and human immunodeficiency virus (HIV). Recent data suggest that chemokines act in concert with neurotransmitters and neuropeptides, such as opioids. This study aimed to determine whether μ-opioid agonists alter the effect of CXCL12 (the specific CXCR4 ligand) on central neurons. Neuronal expression of CXCR4 and μ-opioid receptors (MORs) was analyzed by Western blot, immunostaining, and flow cytometry. Single-cell studies showed that all CXCR4-positive neurons coexpress MORs. Treatment of neuronal cultures with the selective MOR agonist DAMGO or the endogenous peptide endomorphin-1 inhibited intracellular signaling pathways (ERK1/2 and Akt) activated by CXCL12. Furthermore, DAMGO abolished the neuroprotective effect of CXCL12 in N-methyl-d-aspartate (NMDA) neurotoxicity studies. The effects of DAMGO and endomorphin-1 were inhibited by a general or a μ-specific opioid receptor antagonist, and not caused by changes in neuronal CXCR4 levels. DAMGO did not affect CXCL12-induced internalization of CXCR4. The authors propose that interactions between MOR and CXCR4 signaling can modulate the action of CXCL12 on neuronal survival—which may have important implications to neuroAIDS as well as other neuroinflammatory disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bell JE, Arango JC, Robertson R, Brettle RP, Leen C, Simmonds P (2002). HIV and drug misuse in the Edinburgh cohort. J Acquir Immune Defic Syndr 31(Suppl 2): S35-S42.

    PubMed  CAS  Google Scholar 

  • Bell JE, Brettle RP, Chiswick A, Simmonds P (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121(Pt 11): 2043–2052.

    Article  PubMed  Google Scholar 

  • Belmadani A, Tran PB, Ren D, Assimacopoulos S, Grove EA, Miller RJ (2005). The chemokine stromal cellderived factor-1 regulates the migration of sensory neuron progenitors. J Neurosci 25: 3995–4003.

    Article  PubMed  CAS  Google Scholar 

  • Cartier L, Hartley O, Dubois-Dauphin M, Krause KH (2005). Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48: 16–42.

    Article  PubMed  CAS  Google Scholar 

  • Chalasani SH, Baribaud F, Coughlan CM, Sunshine MJ, Lee VM, Doms RW, Littman DR, Raper JA (2003). The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J Neurosci 23: 4601–4612.

    PubMed  CAS  Google Scholar 

  • Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen LY (2004). Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483: 175–186.

    Article  PubMed  CAS  Google Scholar 

  • Chini B, Parenti M (2004). G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32: 325–338.

    Article  PubMed  CAS  Google Scholar 

  • Chuang RY, Suzuki S, Chuang TK, Miyagi T, Chuang LF, Doi RH (2005). Opioids and the progression of simian AIDS. Front Biosci 10: 1666–1677.

    Article  PubMed  CAS  Google Scholar 

  • Donahoe RM, Vlahov D (1998). Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83: 77–87.

    Article  PubMed  CAS  Google Scholar 

  • Eisch AJ, Barrot M, Schad CA, Self DW, Nestler EJ (2000). Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A 97: 7579–7584.

    Article  PubMed  CAS  Google Scholar 

  • Encinas M, Iglesias M, Llecha N, Comella JX (1999). Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 73: 1409–1421.

    Article  PubMed  CAS  Google Scholar 

  • Geminder H, Sagi-Assif O, Goldberg L, Meshel T, Rechavi G, Witz IP, Ben-Baruch A (2001). A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167: 4747–4757.

    PubMed  CAS  Google Scholar 

  • Han Y, Wang J, He T, Ransohoff RM (2001). TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res 888: 1–10.

    Article  PubMed  CAS  Google Scholar 

  • Hauser KF, Houdi AA, Turbek CS, Elde RP, Maxson W 3rd (2000). Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation. Eur J Neurosci 12: 1281–1293.

    Article  PubMed  CAS  Google Scholar 

  • Hu S, Sheng WS, Lokensgard JR, Peterson PK (2005). Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis 191: 886–889.

    Article  PubMed  CAS  Google Scholar 

  • Iglesias M, Segura MF, Comella JX, Olmos G (2003). Muopioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44: 482–492.

    Article  PubMed  CAS  Google Scholar 

  • Kaul M, Lipton SA (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A 96: 8212–8216.

    Article  PubMed  CAS  Google Scholar 

  • Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA (2005). HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12(Suppl 1): 878–892.

    Article  PubMed  CAS  Google Scholar 

  • Khan MZ, Brandimarti R, Patel JP, Huynh N, Wang J, Huang Z, Fatatis A, Meucci O (2004). Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis. AIDS Res Hum Retroviruses 20: 1063–1071.

    Article  PubMed  CAS  Google Scholar 

  • Khan MZ, Shimizu S, Patel JP, Nelson A, Le MT, Mullen-Przeworski A, Brandimarti R, Fatatis A, Meucci O (2005). Regulation of neuronal P53 activity by CXCR 4. Mol Cell Neurosci 30: 58–66.

    Article  PubMed  CAS  Google Scholar 

  • Kivell BM, Day DJ, McDonald FJ, Miller JH (2004). Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats. Brain Res Dev Brain Res 149: 9–19.

    Article  PubMed  CAS  Google Scholar 

  • Klein RS, Rubin JB (2004). Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol 25: 306–314.

    Article  PubMed  CAS  Google Scholar 

  • Klein RS, Rubin JB, Gibson HD, DeHaan EN, Alvarez-Hernandez X, Segal RA, Luster AD (2001). SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 128: 1971–1981.

    PubMed  CAS  Google Scholar 

  • Law PY, Wong YH, Loh HH (2000). Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40: 389–430.

    Article  PubMed  CAS  Google Scholar 

  • Lazarini F, Tham TN, Casanova P, Arenzana-Seisdedos F, Dubois-Dalcq M (2003). Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42: 139–148.

    Article  PubMed  Google Scholar 

  • Lu M, Grove EA, Miller RJ (2002). Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci U S A 99: 7090–7095.

    Article  PubMed  CAS  Google Scholar 

  • Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 95: 14500–14505.

    Article  PubMed  CAS  Google Scholar 

  • Meucci O, Fatatis A, Simen AA, Miller RJ (2000). Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A 97: 8075–8080.

    Article  PubMed  CAS  Google Scholar 

  • Miller RJ, Meucci O (1999). AIDS and the brain: is there a chemokine connection? Trends Neurosci 22: 471–479.

    Article  PubMed  CAS  Google Scholar 

  • Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002). Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31(Suppl 2): S62-S69.

    PubMed  CAS  Google Scholar 

  • Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR (2004). Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. J Neuroimmunol 147: 123–126.

    Article  PubMed  CAS  Google Scholar 

  • Peterson PK, Gekker G, Hu S, Lokensgard J, Portoghese PS, Chao CC (1999). Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology 38: 273–278.

    Article  PubMed  CAS  Google Scholar 

  • Pike LJ (2003). Lipid rafts: bringing order to chaos. J Lipid Res 44: 655–667.

    Article  PubMed  CAS  Google Scholar 

  • Popik W, Alce TM, Au WC (2002). Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol 76: 4709–4722.

    Article  PubMed  CAS  Google Scholar 

  • Rogers TJ, Steele AD, Howard OM, Oppenheim JJ (2000). Bidirectional heterologous desensitization of opioid and chemokine receptors. Ann N Y Acad Sci 917: 19–28.

    Article  PubMed  CAS  Google Scholar 

  • Salzet M, Vieau D, Day R (2000). Crosstalk between nervous and immune systems through the animal kingdom: focus on opioids. Trends Neurosci 23: 550–555.

    Article  PubMed  CAS  Google Scholar 

  • Schabath H, Runz S, Joumaa S, Altevogt P (2006). CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci 119: 314–325.

    Article  PubMed  CAS  Google Scholar 

  • Steele AD, Henderson EE, Rogers TJ (2003). Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 309: 99–107.

    Article  PubMed  CAS  Google Scholar 

  • Stumm RK, Zhou C, Ara T, Lazarini F, Dubois-Dalcq M, Nagasawa T, Hollt V, Schulz S (2003). CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 23: 5123–5130.

    PubMed  CAS  Google Scholar 

  • Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, Rogers TJ (2002). Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A 99: 10276–10281.

    Article  PubMed  CAS  Google Scholar 

  • Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM, Oppenheim JJ, Rogers TJ (2003). Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 74: 1074–1082.

    Article  PubMed  CAS  Google Scholar 

  • Toth PT, Ren D, Miller RJ (2004). Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J Pharmacol Exp Ther 310: 8–17.

    Article  PubMed  CAS  Google Scholar 

  • Tran PB, Miller RJ (2003). Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci 4: 444–455.

    Article  PubMed  CAS  Google Scholar 

  • Wang D, Raehal KM, Bilsky EJ, Sadee W (2001). Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. J Neurochem 77: 1590–1600.

    Article  PubMed  CAS  Google Scholar 

  • Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB (2005). Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Res 65: 11392–11399.

    Article  PubMed  CAS  Google Scholar 

  • Xu W, Yoon SI, Huang P, Wang Y, Chen C, Chong PL, Liu-Chen LY (2006). Localization of the kappa opioid receptor in lipid rafts. J Pharmacol Exp Ther 317: 1295–1306.

    Article  PubMed  CAS  Google Scholar 

  • Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C (2003). HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6: 1064–1071.

    Article  PubMed  CAS  Google Scholar 

  • Zhao H, Loh HH, Law PY (2006). Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol 69: 1421–1432.

    Article  PubMed  CAS  Google Scholar 

  • Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595–599.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olimpia Meucci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, J.P., Sengupta, R., Bardi, G. et al. Modulation of neuronal CXCR4 by the μ-opioid agonist DAMGO. Journal of NeuroVirology 12, 492–500 (2006). https://doi.org/10.1080/13550280601064798

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280601064798

Keywords

Navigation